Literature DB >> 17375136

A large case-control study of common functional SLC6A4 and BDNF variants in obsessive-compulsive disorder.

Jens R Wendland1, Matthew R Kruse, Kiara R Cromer, Kiara C Cromer, Dennis L Murphy.   

Abstract

Both serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) genes have shown positive associations with obsessive-compulsive disorder (OCD) and some other psychiatric disorders, but these results have not been consistently replicated. To explore the hypothesis that this variability might result from the effects of differing combinations of overlooked variants within SLC6A4 together with small OCD and control sample sizes, we studied three common functional polymorphisms (5-HTTLPR, STin2, and the newly discovered SNP, rs25531) in the largest sample size of OCD patients (N=347) and controls (N=749) ever investigated. During methods development, we found evidence for potential SLC6A4 genotyping problems with earlier methodology, a third possible contributor to variability in earlier studies. A fourth possible explanation might be SLC6A4 x BDNF interactions, which prompted us to investigate combined genotypes of BDNF V66M with the three SLC6A4 loci. Except for a nominal association with rs25531 alone, which did not survive correction for multiple comparisons, we found no evidence for any of these other variants being associated alone or together with OCD, and we therefore also examined clinical OCD subtypes within the sample to evaluate clinical heterogeneity. Subgroups based on the age of OCD onset, gender, familiality, factor analysis-derived symptom dimensions, or comorbidity with other psychiatric disorders failed to identify SLC6A4- or BDNF-associated phenotypes, with one exception of overall number of comorbid anxiety disorders being significantly associated with 5-HTTLPR/rs25531. We conclude that despite their attractiveness as candidate genes in OCD, our data provide no support for association in this large OCD patient sample and point toward the need to examine other genes as candidates for risk determinants in OCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17375136     DOI: 10.1038/sj.npp.1301394

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  25 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 2.  Genetics of early-onset obsessive-compulsive disorder.

Authors:  Susanne Walitza; Jens R Wendland; Edna Gruenblatt; Andreas Warnke; Thomas A Sontag; Oliver Tucha; Klaus W Lange
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-06       Impact factor: 4.785

3.  Consideration of the BDNF gene in relation to two phenotypes: hoarding and obesity.

Authors:  Kiara R Timpano; Norman B Schmidt; Michael G Wheaton; Jens R Wendland; Dennis L Murphy
Journal:  J Abnorm Psychol       Date:  2011-08

4.  Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes.

Authors:  Pablo R Moya; Nicholas H Dodman; Kiara R Timpano; Liza M Rubenstein; Zaker Rana; Ruby L Fried; Louis F Reichardt; Gary A Heiman; Jay A Tischfield; Robert A King; Marzena Galdzicka; Edward I Ginns; Jens R Wendland
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

5.  Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive-compulsive disorder.

Authors:  Susanne Walitza; Zoya Marinova; Edna Grünblatt; Stanley E Lazic; Helmut Remschmidt; Timo D Vloet; Jens R Wendland
Journal:  Neurosci Lett       Date:  2014-08-02       Impact factor: 3.046

Review 6.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

Review 7.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

Review 8.  Multiple rare SAPAP3 missense variants in trichotillomania and OCD.

Authors:  S Züchner; J R Wendland; A E Ashley-Koch; A L Collins; K N Tran-Viet; K Quinn; K C Timpano; M L Cuccaro; M A Pericak-Vance; D C Steffens; K R Krishnan; G Feng; D L Murphy
Journal:  Mol Psychiatry       Date:  2009-01       Impact factor: 15.992

Review 9.  Recent advances in the genetics of obsessive-compulsive disorder.

Authors:  Jack F Samuels
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

10.  A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

Authors:  Jens R Wendland; Pablo R Moya; Kiara R Timpano; Adriana P Anavitarte; Matthew R Kruse; Michael G Wheaton; Renee F Ren-Patterson; Dennis L Murphy
Journal:  Arch Gen Psychiatry       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.